Clinical Trials on Ureteropelvic Junction Obstruction in New Zealand

Total 1639 results

Boehringer Ingelheim

Completed

The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the Diskus

Pulmonary Disease, Chronic Obstructive

United States
Avicena LLC

Completed

Vivio AS (Aortic Stenosis) Detection Study

Aortic Stenosis

United States
Xiromed LLC
Laboratorios Liconsa; Exeltis

Completed

Bioequivalence Study of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD) (ARBORUS)

COPD

United States, India
Target PharmaSolutions, Inc.

Recruiting

A Study of Patients With Chronic Disease

Chronic Obstructive Pulmonary Disease | Asthma | Idiopathic Pulmonary Fibrosis | COPD | Respiratory Disease | IPF

United States
Angion Biomedica Corp
CTI Clinical Trial and Consulting Services

Active, not recruiting

Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney

Delayed Graft Function

United States
Gilead Sciences

Completed

Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function

Long QT Syndrome

United States, Romania, Moldova, Republic of
Anna Erenbourg
Sheba Medical Center; San Salvatore Hospital of L'Aquila; Vittore Buzzi Children... and other collaborators

Recruiting

Automated Fetal Cardiac Function in Babies Affected by Heart Diseases

Congenital Heart Defect | Cardiac Function

Israel, Australia, Italy, Mayotte, Poland
SkyePharma AG
Abbott

Completed

A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™ on the Amount, if Any, of Cortisol Produced by the Adrenal Glands

Asthma

United States
Northwell Health

Completed

Single Dose of Furosemide to Improve Respiratory Distress in Moderate to Severe Bronchiolitis

Bronchiolitis

United States
Novartis Pharmaceuticals

Completed

A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation

Chronic Obstructive Pulmonary Disease (COPD)

United States, Colombia, Egypt, Hungary, France, Guatemala, Panama, Slovakia, Slovenia
University of Vermont
Genentech, Inc.

Completed

A Pilot Trial of Rituxan in Refractory Myasthenia Gravis

Refractory Myasthenia Gravis

United States
Somnial Inc

Completed

Early Feasibility Study of Transcutaneous Upper Airway Stimulation in Obstructive Sleep Apnea

Obstructive Sleep Apnea | OSA

United States
Chiesi Farmaceutici S.p.A.

Completed

A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary Disease (GLIMMER)

Chronic Obstructive Pulmonary Disease | COPD

United States
GlaxoSmithKline

Completed

Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)

Pulmonary Disease, Chronic Obstructive

United States
Boehringer Ingelheim

Completed

A Study to Test the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler in People With Chronic Obstructive Pulmonary Disease (COPD) Who Have Different Abilities to Inhale

Pulmonary Disease, Chronic Obstructive

United States, Germany
NeuroDx Development
National Institute of Neurological Disorders and Stroke (NINDS)

Unknown

ShuntCheck-Micro-Pumper Pediatric Clinical Outcomes Study

Suspected CSF Shunt Obstruction

United States
Mackay Memorial Hospital
Seda Chemical Products Co., Ltd.

Unknown

Effects of Head Elevation by a Bed on Sleep-disordered Breathing

Obstructive Sleep Apnea | Sleep-disordered Breathing

Taiwan
AstraZeneca

Completed

A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD

Chronic Obstructive Pulmonary Disease

United States, Bulgaria, Germany, Hungary, Romania, Denmark, Greece, Mexico, Iceland
Novartis Pharmaceuticals

Completed

A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow Limitation

Chronic Obstructive Pulmonary Disease (COPD)

United States, Romania, Hungary, Bulgaria, Spain, Finland, Puerto Rico
Naestved Hospital
Odense University Hospital; Zealand University Hospital; Hvidovre University... and other collaborators

Active, not recruiting

Breathing Exercises in Asthma Targeting Dysfunctional Breathing (BEAT_DB)

Dysfunctional Breathing in Asthma

Denmark
Merck Sharp & Dohme LLC

Completed

Safety and Tolerability of Gefapixant (MK-7264) in Participants With Obstructive Sleep Apnea (MK-7264-039)

Obstructive Sleep Apnea (OSA)

United States, Belgium
AstraZeneca

Completed

A Study for the Assessment of the Words Used by Patients and Physicians to Express the Symptoms of Chronic Obstructive Pulmonary Disease (COPD) (COPD Language)

Chronic Obstructive Pulmonary Disease

Greece
Sumitomo Pharma America, Inc.

Completed

A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer (BRIGHTER)

Gastric Cancer | Gastroesophageal Junction Cancer

United States, Hungary, Spain, China, Brazil, France, Australia, Czechia, Germany, Israel, Canada, United Kingdom, Japan, Belgium, Romania, Italy, Poland, Lithuania, Korea, Republic of, Bulgaria, Estonia, Russian Federation
Novartis Pharmaceuticals

Completed

Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function (LHW090)

Chronic Kidney Disease (CKD)

Germany, United States
Wissenschaftliches Institut Bethanien e.V

Completed

The Debated Role of Sleep Studies in Patients Under Established Home Mechanical Ventilation

Chronic Obstructive Pulmonary Disease | Neuromuscular Diseases | Obesity Hypoventilation Syndrome | Restrictive Lung Disease | Hypoventilation Syndrome

Germany
Pearl Therapeutics, Inc.

Completed

Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

United States
Institut für Pneumologie Hagen Ambrock eV
Fisher and Paykel Healthcare

Completed

Efficacy and Physiology of Nasal High Flow Therapy

Pulmonary Disease, Chronic Obstructive

Germany
Cryosa, Inc.

Recruiting

Clinical Trial of the Cryosa System for the Treatment of Obstructive Sleep Apnea (ARCTIC-3)

Obstructive Sleep Apnea of Adult

United States
Sunovion Respiratory Development Inc.

Completed

A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (GOLDEN-2)

COPD

United States
University of Minnesota
National Heart, Lung, and Blood Institute (NHLBI); Canadian Institutes of Health... and other collaborators

Terminated

Simvastatin Therapy for Moderate and Severe COPD (STATCOPE)

Pulmonary Disease, Chronic Obstructive

United States, Canada
All India Institute of Medical Sciences, New Delhi

Unknown

Effect of CPAP on Biomarkers in Patients With OSA (CPAP)

Obstructive Sleep Apnea

India
Sunovion

Completed

Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD

Chronic Obstructive Pulmonary Disease | Emphysema | Chronic Bronchitis

United States
AstraZeneca

Completed

Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125)

Chronic Obstructive Pulmonary Disease (COPD)

Germany, Spain, United States, Canada, India, Italy, Poland, South Africa
National Cancer Institute (NCI)

Recruiting

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Patients With Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Stage III Uterine Corpus Cancer AJCC v8 | Stage IV Uterine Corpus Cancer AJCC v8 | Metastatic Malignant Solid Neoplasm | Clinical Stage... and other conditions

United States
Novartis Pharmaceuticals

Completed

Lung Function and Patient Preference With QVA149 vs. Tiotropium in COPD Patients (FAVOR)

Chronic Obstructive Pulmonary Disease | COPD

Germany
Direct Flow Medical, Inc.

Unknown

Transcatheter Aortic Valve Replacement System Pivotal Trial (SALUS)

Aortic Valve Stenosis

United States
Columbia University
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Assessment of Continuous Positive Airway Pressure Therapy in IPF (ACT-IPF)

Obstructive Sleep Apnea | Interstitial Lung Disease

United States
Bassett Healthcare
Baylor University

Completed

Podocan and Wnt Pathway in Left Ventricular Remodeling of Aortic Stenosis

Aortic Valve Stenosis

United States
Yale University
Spectranetics Corporation

Completed

Bridge Occlusion Balloon in Lead Extraction Procedure

C.Surgical Procedure; Cardiac | Cardiac Dysrhythmia | Disorder of Pacing Function

United States
AstraZeneca

Completed

Exacerbations and Their Outcomes International (EXACOS International) (EXACOS-Intl)

Chronic Obstructive Pulmonary Disease

Taiwan, Russian Federation, Mexico, Chile
Novartis Pharmaceuticals

Completed

Efficacy and Safety of QMF149 vs. Salmeterol Xinafoate/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)

COPD

Spain, Germany, Belgium, Poland, South Africa, Australia, Greece, Israel, Sweden, Hong Kong, Thailand, Bulgaria, Singapore, Denmark, Finland, Hungary, Romania, Malaysia
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Completed

Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)

Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma | Gastric Cancer Third Line

Spain, Italy, Australia, Korea, Republic of, Belgium, France, Poland, United States, Czechia, Germany
Novartis

Completed

Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks

Chronic Obstructive Pulmonary Disease

United States
Sanofi

Terminated

KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections (KEYS)

Respiratory Tract Infections | Pneumonia | Chronic Bronchitis

United States, Canada
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia

COVID-19 Pneumonia, Impaired Respiratory Function

Germany, India, Spain, Russian Federation, Mexico, Netherlands, Peru, Brazil, Hungary, Argentina, Denmark, South Africa
Imugene Limited

Active, not recruiting

A Study of IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON) (nextHERIZON)

Stomach Cancer | Gastric Cancer | Gastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Cancer of Stomach | Stomach Adenocarcinoma

Taiwan, Australia
LivaNova

Recruiting

Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation (OSPREY)

Apnea | Obstructive Sleep Apnea | OSA | Apnea, Obstructive | Apnea+Hypopnea | Apnea, Obstructive Sleep | Hypopnea, Sleep

United States
National Institute of Environmental Health Sciences...

Completed

Role of the Toxic Metal Cadmium in the Mechanism Producing Infertility With a Varicocele

Male Infertility | Varicocele | Hypospermatogenesis | Non-Obstructive Azoospermia

United States
New York Medical College

Recruiting

Defibrotide Dose-escalation for SOS Post-HSCT

Sinusoidal Obstruction Syndrome | Veno-occlusive Disease

United States
GlaxoSmithKline

Completed

A Study To Assess Efficacy And Safety Of Different Doses Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

United States, Argentina, Estonia, Canada, Chile, Germany, Peru, Philippines, Mexico, Korea, Republic of, Denmark, Russian Federation, Poland, Slovakia

Clinical Trials on Ureteropelvic Junction Obstruction in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations